NCT05274958 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Augusterfer EF, Mollica RF, Lavelle J
Leveraging Technology in Post-Disaster Settings: the Role of Digital Health/Telemental Health. Curr Psychiatry Rep. 2018 Aug 28;20(10):88. doi: 10.1007/s11920-018-0953-4.
Douglas S, Jensen-Doss A, Ordorica C, Comer JS
Strategies to enhance communication with telemental health measurement-based care (tMBC). Pract Innov (Wash D C). 2020 Jun;5(2):143-149. doi: 10.1037/pri0000119.
Kalin ML, Garlow SJ, Thertus K, Peterson MJ
Rapid Implementation of Telehealth in Hospital Psychiatry in Response to COVID-19. Am J Psychiatry. 2020 Jul 1;177(7):636-637. doi: 10.1176/appi.ajp.2020.20040372. No abstract available.
Lambert MJ, Whipple JL, Kleinstauber M
Collecting and delivering progress feedback: A meta-analysis of routine outcome monitoring. Psychotherapy (Chic). 2018 Dec;55(4):520-537. doi: 10.1037/pst0000167.
Lewis CC, Boyd M, Puspitasari A, Navarro E, Howard J, Kassab H, Hoffman M, Scott K, Lyon A, Douglas S, Simon G, Kroenke K
Implementing Measurement-Based Care in Behavioral Health: A Review. JAMA Psychiatry. 2019 Mar 1;76(3):324-335. doi: 10.1001/jamapsychiatry.2018.3329.
Torous J, Wykes T
Opportunities From the Coronavirus Disease 2019 Pandemic for Transforming Psychiatric Care With Telehealth. JAMA Psychiatry. 2020 Dec 1;77(12):1205-1206. doi: 10.1001/jamapsychiatry.2020.1640. No abstract available.

A Comparison of the Effectiveness of Telepsychiatry With a Randomized Waitlist Control Utilizing Patient Reported Outcome Measures (PROMs)

Clinical trial NCT05274958 - References